Breaking News:
Akita Nasal Technology Published in Leading Peer-Reviewed Journal
Read More

INNOVATING FOR A
HEALTHIER TOMORROW

AKITA'S PLATFORM

We’ve developed a versatile platform to rapidly create nasal spray formulations for both broad and personalized health needs. This platform allows us to fine-tune the therapeutic effects of new or existing therapies by optimizing release time and absorption characteristics.

CAPABILITIESSEE THE SCIENCE

OUR PROPRIETARY
PLATFORM

Our technology does more than just nasal delivery; it enables rapid onset, can control mucosal absorption, and optimize the residence time for molecules and biologics.

Functionality

  • Molecule encapsulation
  • Rapid onset
  • Reduces clearance
  • Transiently permeabilize nasal epithelium
  • Self administration

Features

  • Up to  ~150 kDa
  • 2 - 3 m onset
  • 3 - 24 h residence time
  • Able to deliver to
    underlying cells
  • Strong safety profile

applications

  • Respiratory infection prophylactic
  • Enhancing speed & extending release for large molecules
  • Nasal vaccines
  • Nose-to-brain delivery

NASAL  SCIENCE

The nose is the gateway to the respiratory system and plays a critical role in everyday health. In fact, the nasal mucosa filters the air we breathe as part of our respiratory system’s first-line defense against airborne viruses and bacteria. It’s also highly vascularized, enabling the rapid absorption of medications into circulation while avoiding degradation in the GI tract and the liver. The nose also serves as a direct route to the brain.

Due to these distinct advantages, the nose is quickly becoming an accepted route for prophylactics therapies to prevent respiratory infections, receiving much attention for vaccine delivery, and has the potential to enhance clinical benefits for many conventional oral and IV medications such as sedatives, hormones, analgesics, antihistamines, corticosteroids, and more.

Title of Chart Here

Insert the chart here.

Summarize the chart here.

An innovative health & wellness company developing science-backed nasal therapies to prevent airborne infections
About
About Us
Science
See our Platform
Contact
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Join our subscribers lists to get the latest news and updates delivered directly to your inbox.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

SUBSCRIBE TO OUR NEWSLETTER

Join our subscribers lists to get the latest news and updates delivered directly to your inbox.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Contact Us
Contact Us
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure any disease.

SUBSCRIBE TO OUR NEWSLETTER

Join our subscribers lists to get the latest news and updates delivered directly to your inbox.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
© 2024 Akita Biosciences. All rights reserved.